Diabmir

N/A

Report date: 2023/01/07 22:56:37
NME

Base Information

Drug NameDiabmir
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTelomerase activators
TargetsTelomerase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvanced Medical Projects
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A